Your browser doesn't support javascript.
loading
Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
Maokola, Werner M; Ngowi, Bernard J; Mahande, Michael J; Todd, Jim; Robert, Masanja; Msuya, Sia E.
Afiliação
  • Maokola WM; Ministry of Health, Community Development, Gender, Elderly and Children, Dar es Salaam, Tanzania.
  • Ngowi BJ; Institute of Public Health, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
  • Mahande MJ; Mbeya University College of Health Sciences, Mbeya, Tanzania.
  • Todd J; Institute of Public Health, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
  • Robert M; National Institute of Medical Research, Mwanza, Tanzania.
  • Msuya SE; London School of Hygiene and Tropical Medicine, London, United Kingdom.
PLoS One ; 16(7): e0254082, 2021.
Article em En | MEDLINE | ID: mdl-34255776
ABSTRACT

BACKGROUND:

Information on how well Isoniazid Preventive Therapy (IPT) works on reducing TB incidence among people living with HIV (PLHIV) in routine settings using robust statistical methods to establish causality in observational studies is scarce.

OBJECTIVES:

To evaluate the effectiveness of IPT in routine clinical settings by comparing TB incidence between IPT and non-IPT groups.

METHODS:

We used data from PLHIV enrolled in 315 HIV care and treatment clinic from January 2012 to December 2016. We used Inverse Probability of Treatment Weighting to adjust for the probability of receiving IPT; balancing the baseline covariates between IPT and non-IPT groups. The effectiveness of IPT on TB incidence was estimated using Cox regression using the weighted sample.

RESULTS:

Of 171,743 PLHIV enrolled in the clinics over the five years, 10,326 (6.01%) were excluded leaving 161,417 available for the analysis. Of the 24,800 who received IPT, 1.00% developed TB disease whereas of the 136,617 who never received IPT 6,085 (4.98%) developed TB disease. In 278,545.90 person-years of follow up, a total 7,052 new TB cases were diagnosed. Using the weighted sample, the overall TB incidence was 11.57 (95% CI 11.09-12.07) per 1,000 person-years. The TB incidence among PLHIV who received IPT was 10.49 (95% CI 9.11-12.15) per 1,000 person-years and 12.00 (95% CI 11.69-12.33) per 1,000 person-years in those who never received IPT. After adjusting for other covariates there was 52% lower risk of developing TB disease among those who received IPT compared to those who never received IPT aHR = 0.48 (95% CI 0.40-0.58, P<0.001).

CONCLUSION:

IPT reduced TB incidence by 52% in PLHIV attending routine CTC in Tanzania. IPTW adjusted the groups for imbalances in the covariates associated with receiving IPT to achieve comparable groups of IPT and non-IPT. This study has added evidence on the effectiveness of IPT in routine clinical settings and on the use of IPTW to determine impact of interventions in observational studies.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções por HIV / Probabilidade / Análise de Dados / Isoniazida Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn País/Região como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções por HIV / Probabilidade / Análise de Dados / Isoniazida Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn País/Região como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article